Latest Articles
Minimally Invasive Innovation in Endometriosis and Adenomyosis: Toward Fertility Preservation and Symptom Relief.
Published: May 19, 2026, midnight
BBC star left on floor in intense pain as she shares reality of debilitating condition - MSN
BBC star left on floor in intense pain as she shares reality of debilitating condition MSN
Published: May 18, 2026, 11:05 p.m.
Yana Aznavour, MD, PhD, on a non-invasive menstrual blood diagnostic platform for endometriosis - Contemporary OB/GYN
Yana Aznavour, MD, PhD, on a non-invasive menstrual blood diagnostic platform for endometriosis Contemporary OB/GYN
Published: May 18, 2026, 8:17 p.m.
MSD’s sac-TMT meets primary endpoints in Phase III endometrial cancer trial - Yahoo
MSD’s sac-TMT meets primary endpoints in Phase III endometrial cancer trial Yahoo
Published: May 18, 2026, 4:44 p.m.
Bindi Irwin misses gala as health recovery continues - MSN
Bindi Irwin misses gala as health recovery continues MSN
Published: May 18, 2026, 4:42 p.m.
MSD’s sac-TMT meets primary endpoints in Phase III endometrial cancer trial - Clinical Trials Arena
MSD’s sac-TMT meets primary endpoints in Phase III endometrial cancer trial Clinical Trials Arena
Published: May 18, 2026, 4:34 p.m.
MSD's Sac-TMT delivers in first phase 3 readout - pharmaphorum
MSD's Sac-TMT delivers in first phase 3 readout pharmaphorum
Published: May 18, 2026, 3:17 p.m.
Easing pain: Way to slash endometriosis diagnosis by years - NT News
Easing pain: Way to slash endometriosis diagnosis by years NT News
Published: May 18, 2026, 2:19 p.m.
Merck reports positive Phase 3 results for uterine cancer drug - Voice of Healthcare
Merck reports positive Phase 3 results for uterine cancer drug Voice of Healthcare
Published: May 18, 2026, 11:29 a.m.
Merck endometrial cancer drug meets survival goals in phase 3 trial - StreetInsider
Merck endometrial cancer drug meets survival goals in phase 3 trial StreetInsider
Published: May 18, 2026, 10:47 a.m.
Link copied to clipboard!